Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 13 articles: HTML format Text format

Single Articles

June 2018
1. EVA V, Lenka P, Petr H, Milan K, et al
   Clinical and genotypic CMV drug resistance in HSCT recipients: a single center epidemiological and clinical data.
   Bone Marrow Transplant. 2018 Jun 27. pii: 10.1038/s41409-018-0257.
   PubMed     Text format    
   
   
   
2. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
   Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
   Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. METAFUNI E, Chiusolo P, Sica S, Laurenti L, et al
   Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants.
   Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0200.
   PubMed     Text format     Abstract available
   
   
   
4. LINDEMANN M, Eiz-Vesper B, Steckel NK, Tischer S, et al
   Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third-party family donor.
   Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0209.
   PubMed     Text format    
   
   
   April 2018
5. SOLANO C, Talaya A, Gimenez E, Albert E, et al
   Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
   Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
   PubMed     Text format    
   
   
   
6. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
   Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
   Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
   PubMed     Text format     Abstract available
   
   
   
7. ALSULIMAN T, Kitel C, Dulery R, Guillaume T, et al
   Cytotect(R)CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study.
   Bone Marrow Transplant. 2018 Apr 13. pii: 10.1038/s41409-018-0166.
   PubMed     Text format     Abstract available
   
   
   January 2018
8. CESARO S, Crocchiolo R, Tridello G, Knelange N, et al
   Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.
   Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0016.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. ALBERT E, Solano C, Gimenez E, Focosi D, et al
   The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
   Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
   PubMed     Text format     Abstract available
   
   
   June 2017
10. SOLANO C, Gimenez E, Pinana JL, Hernandez-Boluda JC, et al
    When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Text format    
    
    
    February 2017
11. IGLESIAS L, Perera MM, Torres-Minana L, Pena-Lopez MJ, et al
    CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available
    
    
    January 2017
12. SHAW BE, Mayor NP, Szydlo RM, Bultitude WP, et al
    Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
13. BAO X, Zhu Q, Xue S, Xu Y, et al
    Risk factors of clinically refractory CMV reactivation following allogeneic HSCT: a single-center study in China.
    Bone Marrow Transplant. 2016 Oct 17. doi: 10.1038/bmt.2016.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: